Get access

Cognitive behavioural therapy (CBT), third-wave CBT and interpersonal therapy (IPT) based interventions for preventing depression in children and adolescents

  • Conclusions changed
  • Review
  • Intervention




Depression is common in young people. It has a marked negative impact and is associated with self-harm and suicide. Preventing its onset would be an important advance in public health. This is an update of a Cochrane review that was last updated in 2011.


To determine whether evidence-based psychological interventions (including cognitive behavioural therapy (CBT), interpersonal therapy (IPT) and third wave CBT)) are effective in preventing the onset of depressive disorder in children and adolescents.

Search methods

We searched the specialised register of the Cochrane Common Mental Disorders Group (CCMDCTR to 11 September 2015), which includes relevant randomised controlled trials from the following bibliographic databases: The Cochrane Library (all years), EMBASE (1974 to date), MEDLINE (1950 to date) and PsycINFO (1967 to date). We searched conference abstracts and reference lists of included trials and reviews, and contacted experts in the field.

Selection criteria

We included randomised controlled trials of an evidence-based psychological prevention programme compared with any comparison control for young people aged 5 to 19 years, who did not currently meet diagnostic criteria for depression.

Data collection and analysis

Two authors independently assessed trials for inclusion and rated their risk of bias. We adjusted sample sizes to take account of cluster designs and multiple comparisons. We contacted trial authors for additional information where needed. We assessed the quality of evidence for the primary outcomes using GRADE.

Main results

We included 83 trials in this review. The majority of trials (67) were carried out in school settings with eight in colleges or universities, four in clinical settings, three in the community and four in mixed settings. Twenty-nine trials were carried out in unselected populations and 53 in targeted populations.

For the primary outcome of depression diagnosis at medium-term follow-up (up to 12 months), there were 32 trials with 5965 participants and the risk of having a diagnosis of depression was reduced for participants receiving an intervention compared to those receiving no intervention (risk difference (RD) -0.03, 95% confidence interval (CI) -0.05 to -0.01; P value = 0.01). We rated this evidence as moderate quality according to the GRADE criteria. There were 70 trials (73 trial arms) with 13,829 participants that contributed to the analysis for the primary outcome of depression symptoms (self-rated) at the post-intervention time point, with results showing a small but statistically significant effect (standardised mean difference (SMD) -0.21, 95% CI -0.27 to -0.15; P value < 0.0001). This effect persisted to the short-term assessment point (up to three months) (SMD -0.31, 95% CI -0.45 to -0.17; P value < 0.0001; 16 studies; 1558 participants) and medium-term (4 to 12 months) assessment point (SMD -0.12, 95% CI -0.18 to -0.05; P value = 0.0002; 53 studies; 11,913 participants); however, the effect was no longer evident at the long-term follow-up. We rated this evidence as low to moderate quality according to the GRADE criteria.

The evidence from this review is unclear with regard to whether the type of population modified the overall effects; there was statistically significant moderation of the overall effect for depression symptoms (P value = 0.0002), but not for depressive disorder (P value = 0.08). For trials implemented in universal populations there was no effect for depression diagnosis (RD -0.01, 95% CI -0.03 to 0.01) and a small effect for depression symptoms (SMD -0.11, 95% CI -0.17 to -0.05). For trials implemented in targeted populations there was a statistically significantly beneficial effect of intervention (depression diagnosis RD -0.04, 95% CI -0.07 to -0.01; depression symptoms SMD -0.32, 95% CI -0.42 to -0.23). Of note were the lack of attention placebo-controlled trials in targeted populations (none for depression diagnosis and four for depression symptoms). Among trials implemented in universal populations a number used an attention placebo comparison in which the intervention consistently showed no effect.

Authors' conclusions

Overall the results show small positive benefits of depression prevention, for both the primary outcomes of self-rated depressive symptoms post-intervention and depression diagnosis up to 12 months (but not beyond). Estimates of numbers needed to treat to benefit (NNTB = 11) compare well with other public health interventions. However, the evidence was of moderate to low quality using the GRADE framework and the results were heterogeneous. Prevention programmes delivered to universal populations showed a sobering lack of effect when compared with an attention placebo control. Interventions delivered to targeted populations, particularly those selected on the basis of depression symptoms, had larger effect sizes, but these seldom used an attention placebo comparison and there are practical difficulties inherent in the implementation of targeted programmes. We conclude that there is still not enough evidence to support the implementation of depression prevention programmes.

Future research should focus on current gaps in our knowledge. Given the relative lack of evidence for universal interventions compared with attention placebo controls and the poor results from well-conducted effectiveness trials of universal interventions, in our opinion any future such trials should test a depression prevention programme in an indicated targeted population using a credible attention placebo comparison group. Depressive disorder as the primary outcome should be measured over the longer term, as well as clinician-rated depression. Such a trial should consider scalability as well as the potential for the intervention to do harm.

Plain language summary

Evidence-based psychological interventions for preventing depression in children and adolescents

The aim of this review was to assess the efficacy of evidence-based psychological interventions designed to prevent the onset of a depressive disorder and to reduce any existing symptoms of depression.

Who may be interested in this review?

People involved in public health initiatives, school personnel and mental health clinicians.

Why is this review important?

Depressive disorder is common. It is associated with a negative impact on the functioning of young people and is expensive to society at large. Finding a way to prevent the onset of depressive disorder has the potential to make an important impact on the burden of depression in young people.

What questions does this review aim to answer?

Whether psychological depression prevention programmes designed to prevent the onset of depressive disorder in children and adolescents are effective.

Which trials were included in the review?

We included 83 studies (in particular randomised controlled trials) of evidence-based psychotherapy interventions (cognitive behavioural therapy (CBT) and third wave CBT, interpersonal therapy) that had the specific aim of preventing the onset of depressive disorder. For the primary outcome of depression diagnosis at medium-term follow-up (up to 12 months), there were 32 trials with 5965 participants and for the primary outcome of depression symptoms (self-rated) there were 73 trials with 13,829 participants.

What does the evidence from the review tell us?

We found that, compared with any comparison group, psychological depression prevention programmes have small positive benefits on depression prevention. There were some problems with the way the trials were done and in particular the results showed that compared to an attention placebo comparison group (a control intervention that controls for non-specific factors like involvement in a trial and attention from researchers), these programmes had no effect. There is still not enough evidence to support the implementation of depression prevention programmes. However, based on the effects seen for targeted depression prevention programmes (albeit with inadequate control groups), we recommend that further research be undertaken to test the effectiveness of depression prevention programmes in populations of young people who already have some symptoms of depression. Such trials should compare the intervention to an attention placebo comparison group and measure whether depressive diagnosis is prevented in the long term. They also need to consider whether the approach is something that can be implemented in the real world. In addition, they should consider and measure whether the intervention produces harmful outcomes.

Резюме на простом языке

Психологические вмешательства, основанные на доказательствах, для профилактики депрессии у детей и подростков

Целью этого обзора было оценить эффективность основанных на доказательствах психологических вмешательств, разработанных для профилактики развития депрессивного расстройства и уменьшения любых имеющихся симптомов депрессии.

Кому может быть интересен этот обзор?

Людям, участвующим в инициативах в области общественного здоровья, персоналу школ и клиницистам в области психического здоровья.

Почему этот обзор важен?

Депрессивное расстройство является распространенным состоянием. Оно оказывает негативное влияние на активность молодых людей и оборачивается убытками для общества в целом. Поиск способов предотвращения развития депрессивного расстройства может важнейшим образом повлиять на бремя депрессии у молодых людей.

На какие вопросы отвечает этот обзор?

Эффективны ли психологические программы по профилактике депрессии, разработанные для предотвращения развития депрессивного развития у детей и подростков.

Какие исследования были включены в этот обзор?

Мы включили 83 исследования (в частности, рандомизированные контролируемые испытания), посвященные основанным на доказательствах психотерапевтическим вмешательствам (когнитивно-поведенческая терапия (КПТ) и КПТ третьей волны, интерперсональная терапия), направленным на предотвращение развития депрессивного расстройства. Для первичного исхода постановки диагноза депрессии в средне-срочном периоде наблюдения (до 12 месяцев) было 32 клинических испытания с участием 5965 людей, для первичного исхода - симптомов депрессии (оцениваемых самостоятельно участниками) было 73 клинических испытания с участием 13829 людей.

О чем говорят доказательства из этого обзора?

Мы обнаружили, что в сравнении с любой из групп сравнения психологические программы по профилактике депрессии имели небольшую пользу в отношении предотвращения депрессии. Были некоторые проблемы в способе проведения клинических испытаний, в частности, результаты показали, что при сравнении с группой "внимания-плацебо" (контрольное вмешательство, контролирующее неспецифические факторы, такие как вовлеченность в клиническое испытание и внимание со стороны исследователей) эти программы не имели эффекта. До сих пор нет достаточных доказательств в поддержку внедрения программ по профилактике депрессии. Однако, основываясь на эффектах, наблюдаемых при проведении целевых программ по профилактике депрессии (хотя и с неадекватными контрольными группами), мы рекомендуем проведение дальнейших исследований для проверки эффективности программ по профилактике депрессии у молодых людей с уже имеющимися симптомами депрессии. В этих клинических испытаниях следует сравнить вмешательство с группой "внимания-плацебо" и определить, возможно ли диагноз депрессии предотвратить в долгосрочной перспективе. Также необходимо рассмотреть, насколько реально внедрение того или иного подхода на практике. В дополнение, следует рассмотреть и оценить возможность вредных исходов вмешательства.

Заметки по переводу

Перевод: Кукушкин Михаил Евгеньевич. Редактирование: Юдина Екатерина Викторовна. Координация проекта по переводу на русский язык: Cochrane Russia - Кокрейн Россия (филиал Северного Кокрейновского Центра на базе Казанского федерального университета). По вопросам, связанным с этим переводом, пожалуйста, обращайтесь к нам по адресу:;